Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine

NCT04900467 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

418

Enrollment

OTHER

Sponsor class

Conditions

Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose

Interventions

BIOLOGICAL: Pfizer
BIOLOGICAL: Moderna

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]